CHRS Historical PE Ratio image   This CHRS PE ratio history page last updated 12/6/2024
CHRS Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2024
11/6/2024
0.72-0.01-0.04NA
Q2 2024
8/8/2024
1.29-0.14-0.56NA
Q1 2024
5/9/2024
2.12-0.32-1.28NA
Q4 2023
3/13/2024
2.30-0.62-2.48NA
Q3 2023
11/6/2023
3.54-0.27-1.08NA
Q2 2023
8/2/2023
4.34-0.38-1.52NA
Q1 2023
5/8/2023
8.14-0.75-3.00NA
Q4 2022
3/6/2023
6.77-0.60-2.40NA
Q3 2022
11/8/2022
7.99-0.96-3.84NA
Q2 2022
8/4/2022
10.58-0.47-1.88NA
Q1 2022
5/5/2022
8.82-1.00-4.00NA
Q4 2021
2/17/2022
12.85-0.46-1.84NA
Q3 2021
11/8/2021
17.51-0.34-1.36NA
Q2 2021
8/5/2021
12.96-0.36-1.44NA
Q1 2021
5/6/2021
14.500.010.04362.5
Q4 2020
2/24/2021
16.230.230.9217.6
Q3 2020
11/5/2020
18.280.471.889.7
Q2 2020
8/6/2020
17.410.813.245.4
Q1 2020
5/7/2020
16.660.481.928.7
Q4 2019
2/27/2020
19.190.532.129.1
Q3 2019
11/6/2019
16.460.632.526.5
Q2 2019
8/1/2019
17.030.321.2813.3
Q1 2019
5/9/2019
16.10-0.29-1.16NA
Q4 2018
2/28/2019
14.34-0.92-3.68NA
Q3 2018
11/8/2018
11.93-0.87-3.48NA
Q2 2018
8/8/2018
18.35-0.68-2.72NA
Q1 2018
5/10/2018
14.95-0.74-2.96NA
Q4 2017
3/8/2018
9.10-0.84-3.36NA
Q3 2017
11/6/2017
12.25-1.09-4.36NA
Q2 2017
8/7/2017
12.40-1.08-4.32NA
Q1 2017
5/8/2017
20.25-1.54-6.16NA
Q4 2016
3/13/2017
23.45-1.71-6.84NA
Q3 2016
11/9/2016
27.101.676.684.1
Q2 2016
8/9/2016
29.70-1.72-6.88NA
Q1 2016
5/9/2016
19.20-1.67-6.68NA
Q4 2015
2/29/2016
14.19-1.35-5.40NA
Q3 2015
11/9/2015
29.06-1.86-7.44NA
Q2 2015
8/10/2015
33.87-1.56-6.24NA
Q1 2015
5/11/2015
21.08-1.22-4.88NA
Q4 2014
3/23/2015
25.60-1.47-5.88NA
Q3 2014
12/15/2014
13.78-1.79-7.16NA
CHRS PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2024
11/6/2024
0.72-0.01-1.09NA
Q2 2024
8/8/2024
1.29-0.14-1.35NA
Q1 2024
5/9/2024
2.12-0.32-1.59NA
Q4 2023
3/13/2024
2.30-0.62-2.02NA
Q3 2023
11/6/2023
3.54-0.27-2.00NA
Q2 2023
8/2/2023
4.34-0.38-2.69NA
Q1 2023
5/8/2023
8.14-0.75-2.78NA
Q4 2022
3/6/2023
6.77-0.60-3.03NA
Q3 2022
11/8/2022
7.99-0.96-2.89NA
Q2 2022
8/4/2022
10.58-0.47-2.27NA
Q1 2022
5/5/2022
8.82-1.00-2.16NA
Q4 2021
2/17/2022
12.85-0.46-1.15NA
Q3 2021
11/8/2021
17.51-0.34-0.46NA
Q2 2021
8/5/2021
12.96-0.360.3537.0
Q1 2021
5/6/2021
14.500.011.529.5
Q4 2020
2/24/2021
16.230.231.998.2
Q3 2020
11/5/2020
18.280.472.298.0
Q2 2020
8/6/2020
17.410.812.457.1
Q1 2020
5/7/2020
16.660.481.968.5
Q4 2019
2/27/2020
19.190.531.1916.1
Q3 2019
11/6/2019
16.460.63-0.26NA
Q2 2019
8/1/2019
17.030.32-1.76NA
Q1 2019
5/9/2019
16.10-0.29-2.76NA
Q4 2018
2/28/2019
14.34-0.92-3.21NA
Q3 2018
11/8/2018
11.93-0.87-3.13NA
Q2 2018
8/8/2018
18.35-0.68-3.35NA
Q1 2018
5/10/2018
14.95-0.74-3.75NA
Q4 2017
3/8/2018
9.10-0.84-4.55NA
Q3 2017
11/6/2017
12.25-1.09-5.42NA
Q2 2017
8/7/2017
12.40-1.08-2.66NA
Q1 2017
5/8/2017
20.25-1.54-3.30NA
Q4 2016
3/13/2017
23.45-1.71-3.43NA
Q3 2016
11/9/2016
27.101.67-3.07NA
Q2 2016
8/9/2016
29.70-1.72-6.60NA
Q1 2016
5/9/2016
19.20-1.67-6.44NA
Q4 2015
2/29/2016
14.19-1.35-5.99NA
Q3 2015
11/9/2015
29.06-1.86-6.11NA
Q2 2015
8/10/2015
33.87-1.56-6.04NA
Q1 2015
5/11/2015
21.08-1.22NANA
Q4 2014
3/23/2015
25.60-1.47NANA
Q3 2014
12/15/2014
13.78-1.79NANA
Quotes delayed 20 minutes

Email EnvelopeFree CHRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Coherus BioSciences (CHRS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CI PE Ratio History
CINC PE Ratio History
CKPT PE Ratio History
CLBS PE Ratio History
CLDX PE Ratio History
CLNN PE Ratio History
CLOV PE Ratio History
CLPT PE Ratio History
CLRB PE Ratio History
CLSD PE Ratio History
How should the CHRS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Coherus BioSciences. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CHRS Historical PE Ratio page.

What is the average historical PE for CHRS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CHRS historical PE ratio using the annualized quarterly earnings method works out to 48.5.

What is the average historical PE for CHRS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CHRS historical PE ratio using the TTM earnings method works out to 13.5.

On this page we presented the CHRS Historical PE Ratio information for Coherus BioSciences' stock. The average CHRS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 48.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CHRS historical PE based on this TTM earnings result method is 13.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CHRS historical PE result, against the recent PE: when this page was posted on 12/5/2024, the most recent closing price for CHRS had been 1.51, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to 0.35. From these numbers, we calculate the recent CHRS PE on 12/5/2024 based on annualized quarterly EPS was 37.8. Based on CHRS's history, that recent PE is low relative to the historical average, with the recent PE 22.1% lower than the historical average PE across our data set for Coherus BioSciences. Looking at the recent CHRS PE on 12/5/2024 based on TTM EPS, we calculate the ratio at 4.3. Based on CHRS's history, that recent PE is low relative to the historical average, with the recent PE 68.1% lower than the average PE across our Coherus BioSciences data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on CHRS or any other given stock, valuation analysis for CHRS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Coherus BioSciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CHRS. Thanks for visiting, and the next time you need to research CHRS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: HPI Videos, FMN Historical Stock Prices, Institutional Holders of HPX.

 

CHRS Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.